Keratocan (KERA) (C-Term) Peptide
KERA
Reactivity: Human, Mouse
Host: Synthetic
BP, WB
-
- Target See all KERA products
- KERA (Keratocan (KERA))
- Protein Region
- C-Term
- Origin
- Human, Mouse
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- MQLNMAKNAL RNMPPRLPAN TMQLFLDNNS IEGIPENYFN VIPKVAFLRL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Kera Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- KERA (Keratocan (KERA))
- Synonyms
- KERA Peptide, si:dkeyp-38g8.3 Peptide, zgc:136259 Peptide, CNA2 Peptide, SLRR2B Peptide, keratocan Peptide, KERA Peptide, kera Peptide, Kera Peptide
- Background
-
Kera may be important in developing and maintaining corneal transparency and for the structure of the stromal matrix.
Alias Symbols: CNA2, SLRR2B
Protein Size: 351 - Molecular Weight
- 39 kDa
- Gene ID
- 16545
- NCBI Accession
- NM_008438, NP_032464
- UniProt
- O35367
-
You are here:
